Facilitated completion of 1-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer by medical oncologists
ConclusionsMedical oncologists may facilitate completion of adjuvant S-1 monotherapy.
CONCLUSIONS: the NACT interval time prior gastrectomy for locally advanced GC is not associated with ypCR or DS and has no impact on overall survival. PMID: 32496120 [PubMed - as supplied by publisher]
CONCLUSION: The rate and severity of complications following LSNNS for early gastric cancer are comparable to those after LSG with lymph node dissection. Registration number: NCT01804998 ( http://www.clinicaltrials.gov). PMID: 32492186 [PubMed - as supplied by publisher]
AbstractBackgroundThe purpose of this study was to investigate clinical features, prognostic factors, and overall survival (OS) in surgical patients with gastric remnant cancer (GRC).MethodsA retrospective analysis of patients with gastrectomy for pT1 –4 gastric cancer between October 1972 and February 2014 at our institution was performed. Clinical characteristics were compared between patients with GRC and those with primary gastric cancer (PGC). Multivariable Cox regression analysis was performed to determine the prognostic factors for OS in patients with GRC. A propensity score-matched cohort was used to investig...
ConclusionAge and the SFA were independent risk factors for extraction site incisional hernia in patients undergoing gastrectomy for gastric cancer.
This study aimed to evaluate the usefulness of HALDG compared with laparoscopy-assisted distal gastrectomy (LADG). Consecutive patients who underwent HALDG (n=58) or LADG (n=90) for stage I gastric cancer between 2005 and 2016 were eligible. Operative time was significantly shorter and blood loss was significantly higher in HALDG than in LADG (P
The lack of widespread use of endoscopic resection (ER) for treatment of early gastric cancer (EGC) meeting the Japanese Gastric Cancer Association (JGCA) absolute and expanded criteria in the U.S., has resulted in unnecessary surgical gastrectomy. We aim to evaluate the inappropriate rates of surgical resection of EGC meeting JGCA absolute and expanded criteria.
Endoscopic submucosal dissection (ESD) is a curative method for some cases of early gastric cancer (EGC). However, there are still some patients who underwent additive gastrectomy after ESD because of lymph node metastasis (LNM) risk. If an accurate predicting for the risk of LNM before ESD is possible, appropriate treatment strategy could be established at the timing of decision for ESD. We aimed to investigate pre-procedural features for predicting the risk of LNM in EGC.
Abstract In recent times, the diagnosis and treatment of superficial laryngopharyngeal cancers has been receiving a lot of attention. Here, we present a case of superficial hypopharyngeal cancer and superficial esophageal cancer for which endoscopic laryngo-pharyngeal surgery (ELPS) and endoscopic submucosal dissection (ESD) were performed simultaneously. The patient was a 67-year-old male. During his follow-up for distal gastrectomy performed earlier for stomach cancer, an upper gastrointestinal endoscopy revealed three primary cancers: superficial hypopharyngeal cancer, superficial esophageal cancer, and esophag...
Condition: QOL; Quality of Life;Gastric Cancer; Gastrectomy;Neoadjuvant Chemotherapy Intervention: Drug: Neoadjuvant Chemotherapy Sponsor: Beijing Cancer Hospital Recruiting
Application of endoscopic submucosal dissection (ESD) for treating undifferentiated-type early gastric cancers (EGCs) remains controversial. Therefore, we aimed to compare long-term outcomes of ESD with those of surgery for patients with undifferentiated-type EGCs by a retrospective study. We retrospectively reviewed data of patients who underwent curative ESD or gastrectomy for undifferentiated-type EGCs between 2010 and 2017. Gastric cancers were undifferentiated-type adenocarcinoma without ulceration confined to the mucosal layer and 2 cm or smaller in size. Demographics, complications, recurrence cancer rates, and s...